arrow
C

Clarissa Filorizzo

azienda sanitaria provinciale di agrigento
H指数:11
被引数:523

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer
2023-05-137
OAAI
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?
2022-09-219
OAAI
Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength

识别Lynch综合征相关结直肠癌患者的不同选择方法的影响: 团结是力量

2022-02-098
OAAI
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?

MSI/MMR状态的肿瘤不可知评估能否成为几种实体瘤患者免疫治疗的共同标准?

2022-02-0121
PRE
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome

乳腺癌/卵巢癌中不确定意义的生殖系BRCA1和BRCA2变异的患病率和谱: 来自基因组的神秘信号

2021-06-1121
OAAI
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype-phenotype correlation in a cohort of 531 patients

三阴性与管腔样乳腺癌的BRCA1/2致病变异: 531例患者的基因型-表型相关性

2020-12-1637
OAAI
The prognostic impact of tissue tumour mutational burden (TMB) in the first-line treatment of advanced non-oncogene addicted non-small cell lung cancer (NSCLC): A systematic review and meta-analysis of randomized controlled trials
2020-09-010
OAAI